Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2BENLYSTA

02 1CABLIVI

03 1CINQAIR

04 1DOXIL (LIPOSOMAL)

05 1DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)

06 1EPOPROSTENOL SODIUM

07 1METHERGINE

08 1MYALEPT

09 1SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE

10 1SYLVANT

11 1VELETRI

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BIO Partnering at JPM
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

CAPLACIZUMAB-YHDP

Drug : CABLIVI

Dosage Form : INJECTABLE; INJECTION

Application Number : 761112

Country : US

Patented : No

Sanofi Company Banner

02

arrow
BIO Partnering at JPM
Not Confirmed

03

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

DOXORUBICIN HYDROCHLORIDE

Drug : DOXIL (LIPOSOMAL)

Dosage Form : INJECTABLE, LIPOSOMAL; INJECTION

Application Number : 50718

Country : US

Patented : No

blank

04

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

METHYLERGONOVINE MALEATE

Drug : METHERGINE

Dosage Form : INJECTABLE; INJECTION

Application Number : 6035

Country : US

Patented : No

blank

05

arrow
BIO Partnering at JPM
Not Confirmed

06

arrow
BIO Partnering at JPM
Not Confirmed

07

arrow
BIO Partnering at JPM
Not Confirmed

08

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

EPOPROSTENOL SODIUM

Drug : EPOPROSTENOL SODIUM

Dosage Form : INJECTABLE; INJECTION

Application Number : 210473

Country : US

Patented : No

blank

09

arrow
BIO Partnering at JPM
Not Confirmed
arrow
BIO Partnering at JPM
Not Confirmed

DOXORUBICIN HYDROCHLORIDE

Drug : DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)

Dosage Form : INJECTABLE, LIPOSOMAL; INJECTION

Application Number : 203263

Country : US

Patented : No

blank

10

arrow
BIO Partnering at JPM
Not Confirmed